Urged By US FDA To Boost Infant Formula Supply, Additional Providers Still Must Wait For Approval

Patricia Hansen, CFSAN’s Office of Nutrition and Food Labeling deputy director and John Verbeten, deputy director for Import Operations Enforcement laid out the FDA's new enforcement guidance, and urged businesses with available formula to wait for approval before distributing formula in the US.

• Source: Shutterstock (Shutterstock)

Manufacturers responding to the US Food and Drug Administration's request for additional infant formula production need to wait for approval before distribution even if they have products ready to go, the agency's Center for Food Safety and Applied Nutrition cautions.

“Do not ship your products, until you have submitted a request to us for enforcement discretion to the portal that's...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from Regulation

More from Policy & Regulation